# NeuroTherapeutics Pharma, Inc. — Form D

NeuroTherapeutics Pharma, Inc. of CHICAGO, IL, a company, filed a Form D exempt-offering notice with the SEC on 2011-12-21. The offering totals $47.5M, of which $12.0M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2011-12-21
- Form: D
- Accession: 0001137638-11-000009
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $47.5M
- Amount sold: $12.0M
- Remaining: $35.5M
- Investors: 8
- Date of first sale: 2011-12-15
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-170464

## Issuer

- Name: NeuroTherapeutics Pharma, Inc.
- CIK: 0001385386
- Entity type: Corporation
- Jurisdiction: DE
- Incorporated: 2006
- Address: 8420 W. BYRN MAWR AVENUE, CHICAGO, IL, 60631
- Phone: (773) 444-4180

## Officers, directors & promoters (21)

| Name | Role | Location |
| --- | --- | --- |
| THOMAS R BECK, M.D. | Director | CHICAGO, IL |
| JASON A BROWN, PH.D. | Director | CHICAGO, IL |
| STEPHEN D COLLINS, M.D., PH.D. | Director | CHICAGO, IL |
| RAJEEV R DADOO, Ph.D. | Director | CHICAGO, IL |
| LUKE A EVNIN, Ph.D. | Director | CHICAGO, IL |
| COREY A GOODMAN, Ph.D. | Director | CHICAGO, IL |
| ELAINE V JONES, PH.D. | Director | CHICAGO, IL |
| HEATH R LUKATCH, Ph.D. | Director | CHICAGO, IL |
| HOLLI A CARLSON | Executive Officer | CHICAGO, IL |
| STEPHEN D COLLINS, M.D., PH.D. | Executive Officer | CHICAGO, IL |
| MICHAEL P VENUTI, Ph.D | Executive Officer | CHICAGO, IL |
| TODD P VERDOORN, Ph.D. | Executive Officer | CHICAGO, IL |
| STEPHEN P WANASKI | Executive Officer | CHICAGO, IL |
| BRIAN B WILLIAMS | Executive Officer | CHICAGO, IL |
| Heath Lukatch, Ph.D. | Director | Redwood City, CA |
| Christine P Siu | Director | Boston, MA |
| Karen Boezi | Director | Kensington, CA |
| Stephen P Wanaski, Ph.D. | Executive Officer | Chicago, IL |
| Corey P Goodman, Ph.D. | Director | Chicago, IL |
| Luke P Evnin, Ph.D. | Director | Chicago, IL |
| Phillip F Morgan, Ph.D. | Director | Chicago, IL |

## Other filings by this issuer (2)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2010-05-28](https://search.stillhousedata.com/formd/0001137638-10-000001) | D | $43.5M | $18.5M |
| [2009-01-06](https://search.stillhousedata.com/formd/0001385386-09-000003) | D | $5.8M | $3.2M |

## More

- [CIK 1385386 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1385386&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001137638-11-000009.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.